Time Savings | Glytec

June 21, 2017

With Glytec, Hospital Moves to Basal-Bolus Insulin, Saves $9.7 Million

The move to quality ratings will put more pressure on hospitals to find ways to improve the standard of care while cutting costs.

A decade ago, the American Diabetes Association (ADA) called for hospitals to shift from sliding scale to subcutaneous basal-bolus insulin therapy for non-critically ill patients, but change has been slow in coming. Fear of hypoglycemia and concerns that staff would not be able to keep up with dosing demands of basal-bolus kept hospitals from upgrading to the standard of care.

June 20, 2016

Glytec Presents Evidence on How Using Data to Deliver Insulin Improves Outcomes

Using an algorithm to recommend insulin dosing, both in and out of the hospital, was shown to improve glycemic control and aid population health management.

The march toward value-based care is occurring on many fronts, with diabetes quality metrics front and center. Providers from giant hospital systems to primary care practices are looking for ways to find savings—and make patients healthier. In this mix is Glytec, a 10-year-old company founded on the idea that taking guesswork and time out of insulin dosing, first in hospital settings and then outside them, could dramatically reduce episodes of hypo- and hyperglycemia. This would provide savings and lead to better glycated hemoglobin (A1C) levels for patients with previously uncontrolled diabetes.

May 22, 2014

Duke University School of Nursing Study Shows Major Tertiary Hospital Saves More Than 72 Minutes Per Nurse While Improving Clinical Outcomes Using eGlycemic Management System

Time and motion study poster presented during AACE shows increased efficiency in insulin management and improved rates of hyperglycemia and hypoglycemia.

Glytec, a clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control, is pleased to share the results of a late-breaking poster that was presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific and Clinical Congress. The poster, “New Interfaces for eGlycemic Management System Saves Nursing Time and Improves Patient Outcomes: Time and Motion Nursing Study,” is based on a study that shows a reduction in nursing time and improvements in both patient outcomes and nurse satisfaction through the integration of Glytec’s eGlycemic Management System® (eGMS®).

May 13, 2014

Glytec Announces Late Breaking Abstracts Accepted for Poster Presentations at American Association of Clinical Endocrinologists 23rd Annual Scientific & Clinical Congress

Conducted by researchers from Duke University School of Nursing, Piedmont Healthcare, Jackson Madison County General Hospital, Sentara Health System and Eastern Virginia Medical School, the poster presentations will highlight research results evaluating Glytec’s eGlycemic Management System® in three leading acute care hospitals.

Glytec, LLC, a clinical information technology company dedicated to the mission of improving insulin management and glycemic control, announced today that several late breaking abstracts featuring the company’s eGlycemic Management System have been accepted for poster presentations at the American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress, taking place from May 14 – May 18, 2014, in Las Vegas. The posters will be displayed from 9:30 a.m. to 1:00 p.m. on Saturday, May 17th in the General Poster Sessions in the exhibit hall. Presentations by the lead authors will occur from 9:45 a.m. to 11:00 a.m. on Saturday, May 17th.